Position history for Nuveen, LLC's holdings in REGENERON PHARMACEUTICALS
Nuveen, LLC holds 2.1M shares of REGN (REGENERON PHARMACEUTICALS), worth $1.6B as of 2026-Q1. The position was increased (+2.7% shares). REGN represents 0.4% of Nuveen, LLC's portfolio.
Current Value
$1.6B
Current Shares
2.1M
Total Value Change
+$1.3B
Total Shares Change
+1.5M
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 2.1M |
+2.7% |
| $1.6B |
| 0.4% |
| $766.66 |
39 |
| 2025-Q4 | Increased | 2M | +71.1% | $1.6B | 0.4% | $773.94 | 57 |
| 2025-Q3 | Increased | 1.2M | +39.7% | $660.8M | 0.2% | $560.05 | 50 |
| 2025-Q2 | Increased | 841,549 | +55.3% | $441.8M | 0.1% | $519.56 | 53 |
| 2025-Q1 | New | 542,018 | - | $343.8M | 0.1% | $634.66 | 51 |